Developer of a novel device designed to offer prostate cancer detection and tissue sampling. The company's device avoids the traditional ultrasound-guided prostate biopsy, enabling health care providers to offer a more efficient and accurate diagnosis.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
4. Early Stage VC | 04-Jan-2018 | Completed | Generating Revenue | |||
3. Grant | 01-Jan-2018 | 00000 | Completed | Generating Revenue | ||
2. Grant | Completed | Startup | ||||
1. Accelerator/Incubator | Completed | Startup |
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Fergus Coakley | Founder, Inventor & Advisor | ||
Robert DuFresne Jr. | Chief Executive Officer |
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Alignment Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
National Science Foundation | Government | 000 0000 | 000000 0 | ||
Oregon Nanoscience and Microtechnologies Institute | University | 000 0000 | 000000 0 | ||
OTRADI Bioscience Incubator | Accelerator/Incubator | 000 0000 | 000000 0 |